new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge bioinformatics software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one bioinformatics software provider empowering you from Sample to Insight.
Imagine this scenario: You are working on a high profile scientific finding (for example the Nevada...
The Human Gene Mutation Database (HGMD®) Professional has over 298,000 inherited disease-relevant m...
We've got a useful tip that will help you get even more value out of QIAGEN CLC Microbial Genomics M...
Read about how researchers across the world are using QIAGEN Digital Insights solutions to accelerat...
'Omics research has made it easy to gather large volumes of data on differentially expressed genes i...
Get the job done: How to maximize productivity in the Nevada SARS-CoV-2 reinfection case study
Using HGMD Public? Your Data Is 3 Years Behind
OTU clustering using the latest version of SILVA OTU database from within QIAGEN CLC Microbial Genomics Module
QIAGEN Digital Insights Publication Roundup (Fall 2020)
The secrets to pathway analysis
Targeted NGS panels and optimized analysis and interpretation bioinformatics software tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics software and services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients